Philippe holds a PhD in Pharmacology from the University of Dijon. He started his scientific career as a project manager for Debiopharm. He is the founder (in 1995) and current CEO of ONCODESIGN. Oncodesign is a 250-person biopharmaceutical company whose mission is to discover effective therapies for the benefit of patients with pathologies without therapeutic solutions.
Philippe is also the founder of the GIE Pharm’Image, Dijon, and has participated in the steering committee of the Centre anti-cancer Georges François Leclerc and is a member of the Board of Directors and the Executive Board of Medicen for the College of VSEs and SMEs.